Source: TBS Report

06 July, 2022, 07:50 pm

Bidding to set the cut-off price – the offer price at which shares get issued to investors – for the shares of Navana Pharmaceuticals which will raise capital from stock markets under the book building method ends on Thursday.

The share price will be determined based on offers made by eligible investors – institutions and high net worth individuals – in the electronic subscription system.

General investors will receive the primary shares at a 30% discount on the cut-off price.

The bidding for the company started from 5 pm on 4 July, which will continue till 5 pm Thursday.

The principal activities of the company are manufacturing, marketing and distribution of pharmaceutical products for human and animal health and sales of the produced items in the domestic and foreign markets.

The company is currently marketing 48 human and 48 veterinary products.

Navana Pharmaceuticals will expand its business

Starting its business journey in 1986, Navana Pharmaceuticals will now expand its business.

The company will raise capital of Tk75 crore by issuing shares to stock investors as an alternative source of finance instead of bank loans.

According to its IPO prospectus, the company will use the fund to renovate its cephalosporin unit and build manufacturing, utilities and engineering buildings.

The company has a factory at Rupshi in Narayanganj. The general production unit and the veterinary production unit went into operation in 1986 and 2003 respectively.

Financial status

The financial accounts for the last five years indicate that the company’s business in the local market and exports have been steadily increasing.

Its products are exported to Myanmar, Vietnam, Sri Lanka, Kenya, and Hong Kong.

Navana Pharmaceuticals had total revenue of over Tk243 crore in fiscal 2017-2018, of which over Tk223 crore was local sales and Tk10.82 crore was exports.

Five years later, in fiscal 2020-21, the company’s revenue increased to Tk360 crore, of which domestic sales are Tk336 crore and exports are Tk24 crore.

In the first nine months of fiscal 2021-22, its earnings per share (EPS) were Tk2.39.

Navana Pharma / Share Price / bidding

You may also like

view all news
August 19, 2022


নাভানা ফার্মাসিউটিক্যালস আইপিও আবেদনের তারিখ নির্ধারণ : Subscription :Open : 13 September Subscription : …

Read More
July 31, 2022

Marico revenues grow but higher taxes erode profits

Source: TBS 27 July, 2022, 09:35 pm The profit margin of Marico Bangladesh Limited – an India-based multinational company – shrank in the March-June quarter – despite a 9% growth in revenue – …

Read More
July 19, 2022

How Factor Investing Works, Using Everyday Examples

Factor Investing: How You May Experience it Why do investments perform the way they do? This is a question many investment experts have been attempting to answer for years. Luckily, factor investing c …

Read More
July 18, 2022

The Largest Importers of Russian Fossil Fuels Since the Ukraine War

Who’s Still Buying Fossil Fuels From Russia? The Largest Importers of Russian Fossil Fuels Since the War Despite looming sanctions and import bans, Russia exported $97.7 billion worth …

Read More
July 17, 2022

The smart investor’s guide to evaluating investment return performance

Source: DhakaTribune June 22, 2022 6:46 PM If you truly want an idea of how well your portfolio is doing, you need something to compare the return with your invested capital. It took you several month …

Read More